Martina de Zwaan, MD; Stephan Herpertz, MD; Stephan Zipfel, MD; et al.
free access
JAMA Psychiatry. 2017;74(10):987-995. doi:10.1001/jamapsychiatry.2017.2150
This randomized clinical trial evaluates the efficacy of internet-based guided self-help compared with traditional, face-to-face, individual cognitive behavior therapy.
Jochen René Thyrian, PhD; Johannes Hertel, Dipl-Psych; Diana Wucherer, Dipl-Pharm; et al.
free access
JAMA Psychiatry. 2017;74(10):996-1004. doi:10.1001/jamapsychiatry.2017.2124
This randomized clinical trial tests the effectiveness and safety of dementia care management in the treatment and care of people with dementia living at home and caregiver burden.
Lars Vedel Kessing, MD, DMSc; Thomas Alexander Gerds, MSc, PhD; Nikoline Nygård Knudsen, MSc; et al.
free access
JAMA Psychiatry. 2017;74(10):1005-1010. doi:10.1001/jamapsychiatry.2017.2362
This case-control study investigates whether the incidence of dementia in the general population covaries with long-term exposure to microlevels of lithium in drinking water.
-
Editorial
Could Lithium in Drinking Water Reduce the Incidence of Dementia?
John J. McGrath, PhD, MD; Michael Berk, PhD
JAMA Psychiatry
Cosima Locher, PhD; Helen Koechlin, MSc; Sean R. Zion, MA; et al.
free access
JAMA Psychiatry. 2017;74(10):1011-1020. doi:10.1001/jamapsychiatry.2017.2432
This systematic review and meta-analysis examines the responses of children and adolescents with common psychiatric disorders who receive selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, or placebo.
-
Editorial
Effectiveness and Safety of Antidepressants for Children and Adolescents: Implications for Clinical Practice
Sally Nicola Merry, MBChB, MD, FRANZCP; Sarah Elisabeth Hetrick, DPsych, MA, PGCertHSc; Karolina Stasiak, PhD
JAMA Psychiatry
Patricia Moreno-Peral, PhD; Sonia Conejo-Cerón, PhD; Maria Rubio-Valera, PhD; et al.
free access
JAMA Psychiatry. 2017;74(10):1021-1029. doi:10.1001/jamapsychiatry.2017.2509
This systematic review, meta-analysis, and meta-regression evaluates the use of psychological and/or educational interventions in prevention of anxiety.
-
Invited Commentary
Prevention of Anxiety Disorders Across the Lifespan
Jennifer L. Hudson, PhD
JAMA Psychiatry
Alexander Viktorin, PhD; Rudolf Uher, MD, PhD; Alexander Kolevzon, MD; et al.
free access
JAMA Psychiatry. 2017;74(10):1031-1038. doi:10.1001/jamapsychiatry.2017.1727
This population-based cohort study examines the association of maternal antidepressant medication use during pregnancy with intellectual disability in offspring and investigates the importance of parental mental illness for such an association.
Eric S. Kim, PhD; Ichiro Kawachi, MD, PhD; Ying Chen, ScD; et al.
free access
JAMA Psychiatry. 2017;74(10):1039-1045. doi:10.1001/jamapsychiatry.2017.2145
This longitudinal cohort study uses data from the Health and Retirement Study to assess whether higher purpose in life among adequately functioning older adults is associated with lower risk of developing weak grip strength and slow walking speed over time.
Kenneth K. C. Man, MPH; David Coghill, MD; Esther W. Chan, PhD; et al.
free access
JAMA Psychiatry. 2017;74(10):1048-1055. doi:10.1001/jamapsychiatry.2017.2183
This population-based, case series study examines the incidence of suicide attempts during treatment with methylphenidate in patients with attention-deficit/hyperactivity disorder.
Stephen T. Higgins, PhD; Sarah H. Heil, PhD; Stacey C. Sigmon, PhD; et al.
free access
JAMA Psychiatry. 2017;74(10):1056-1064. doi:10.1001/jamapsychiatry.2017.2355
This multisite, double-blind, within-participant assessment examines the dose-dependent association of cigarettes with reduced nicotine content with the reinforcing effects, subjective effects, and smoking topography in populations with psychiatric and socioeconomic vulnerabilities.
Olav B. Smeland, MD, PhD; Oleksandr Frei, PhD; Karolina Kauppi, PhD; et al.
free access
JAMA Psychiatry. 2017;74(10):1065-1075. doi:10.1001/jamapsychiatry.2017.1986
This analysis of genome-wide association studies identifies genomic regions jointly influencing schizophrenia and the cognitive domains of reaction time and verbal-numerical reasoning, as well as general cognitive function.